• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过迁移学习对全癌基因组中背景突变率进行元素特异性估计。

Element-specific estimation of background mutation rates in whole cancer genomes through transfer learning.

作者信息

Bahari Farideh, Ahangari Cohan Reza, Montazeri Hesam

机构信息

Department of Nanobiotechnology, New Technologies Research Group, Pasteur Institute of Iran, Tehran, Iran.

Department of Bioinformatics, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.

出版信息

NPJ Precis Oncol. 2025 Mar 29;9(1):92. doi: 10.1038/s41698-025-00871-3.

DOI:10.1038/s41698-025-00871-3
PMID:40155429
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11953285/
Abstract

Mutational burden tests are essential for detecting signals of positive selection in cancer driver discovery by comparing observed mutation rates with background mutation rates (BMRs). However, accurate BMR estimation is challenging due to the diversity of mutational processes across genomes, complicating driver discovery efforts. Existing methods rely on various genomic regions and features for BMR estimation but lack a model that integrates both intergenic intervals and functional genomic elements on a comprehensive set of genomic features. Here, we introduce eMET (element-specific Mutation Estimator with boosted Trees), which employs 1372 (epi)genomic features from intergenic data and fine-tunes it with element-specific data through transfer learning. Applied to PCAWG somatic mutations, eMET significantly improves BMR accuracy and has potential to enhance driver discovery. Additionally, we provide an extensive analysis of BMR estimation, examining different machine learning models, genomic interval strategies, feature categories, and dimensionality reduction techniques.

摘要

通过将观察到的突变率与背景突变率(BMR)进行比较,突变负担测试对于在癌症驱动因素发现中检测正选择信号至关重要。然而,由于整个基因组中突变过程的多样性,准确估计BMR具有挑战性,这使得驱动因素发现工作变得复杂。现有方法依靠各种基因组区域和特征来估计BMR,但缺乏一个在一整套基因组特征上整合基因间间隔和功能基因组元件的模型。在这里,我们引入了eMET(带增强树的元素特异性突变估计器),它利用来自基因间数据的1372个(表观)基因组特征,并通过迁移学习用元素特异性数据对其进行微调。应用于PCAWG体细胞突变时,eMET显著提高了BMR的准确性,并具有增强驱动因素发现的潜力。此外,我们对BMR估计进行了广泛分析,研究了不同的机器学习模型、基因组区间策略、特征类别和降维技术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be29/11953285/9ba62d832f42/41698_2025_871_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be29/11953285/9c26ec8767dd/41698_2025_871_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be29/11953285/71a1672cb60d/41698_2025_871_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be29/11953285/b90ace9ebf49/41698_2025_871_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be29/11953285/ec68b3877fbb/41698_2025_871_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be29/11953285/2d8846aca462/41698_2025_871_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be29/11953285/9ba62d832f42/41698_2025_871_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be29/11953285/9c26ec8767dd/41698_2025_871_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be29/11953285/71a1672cb60d/41698_2025_871_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be29/11953285/b90ace9ebf49/41698_2025_871_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be29/11953285/ec68b3877fbb/41698_2025_871_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be29/11953285/2d8846aca462/41698_2025_871_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be29/11953285/9ba62d832f42/41698_2025_871_Fig6_HTML.jpg

相似文献

1
Element-specific estimation of background mutation rates in whole cancer genomes through transfer learning.通过迁移学习对全癌基因组中背景突变率进行元素特异性估计。
NPJ Precis Oncol. 2025 Mar 29;9(1):92. doi: 10.1038/s41698-025-00871-3.
2
Finding driver pathways in cancer: models and algorithms.寻找癌症中的驱动通路:模型与算法
Algorithms Mol Biol. 2012 Sep 6;7(1):23. doi: 10.1186/1748-7188-7-23.
3
Combined burden and functional impact tests for cancer driver discovery using DriverPower.利用 DriverPower 进行癌症驱动基因发现的综合负担和功能影响测试。
Nat Commun. 2020 Feb 5;11(1):734. doi: 10.1038/s41467-019-13929-1.
4
Pan-cancer analysis of whole genomes.泛癌症全基因组分析。
Nature. 2020 Feb;578(7793):82-93. doi: 10.1038/s41586-020-1969-6. Epub 2020 Feb 5.
5
A site specific model and analysis of the neutral somatic mutation rate in whole-genome cancer data.全基因组癌症数据中特定部位中性体细胞突变率的模型和分析。
BMC Bioinformatics. 2018 Apr 19;19(1):147. doi: 10.1186/s12859-018-2141-2.
6
NIMBus: a negative binomial regression based Integrative Method for mutation Burden Analysis.NIMBus:一种基于负二项回归的突变负担分析综合方法。
BMC Bioinformatics. 2020 Oct 22;21(1):474. doi: 10.1186/s12859-020-03758-1.
7
Mutation-Attention (MuAt): deep representation learning of somatic mutations for tumour typing and subtyping.突变注意力(MuAt):用于肿瘤分型和亚型分类的体细胞突变的深度表示学习。
Genome Med. 2023 Jul 7;15(1):47. doi: 10.1186/s13073-023-01204-4.
8
Sequence dependencies and mutation rates of localized mutational processes in cancer.癌症中局部突变过程的序列依赖性和突变率。
Genome Med. 2023 Aug 17;15(1):63. doi: 10.1186/s13073-023-01217-z.
9
MutEnricher: a flexible toolset for somatic mutation enrichment analysis of tumor whole genomes.MutEnricher:一个用于肿瘤全基因组体细胞突变富集分析的灵活工具集。
BMC Bioinformatics. 2020 Jul 31;21(1):338. doi: 10.1186/s12859-020-03695-z.
10
Candidate Cancer Driver Mutations in Distal Regulatory Elements and Long-Range Chromatin Interaction Networks.远端调控元件和长程染色质互作网络中的候选癌症驱动突变。
Mol Cell. 2020 Mar 19;77(6):1307-1321.e10. doi: 10.1016/j.molcel.2019.12.027. Epub 2020 Jan 17.

本文引用的文献

1
Conservation assessment of human splice site annotation based on a 470-genome alignment.基于470个基因组比对的人类剪接位点注释的保守性评估。
Nucleic Acids Res. 2025 Mar 20;53(6). doi: 10.1093/nar/gkaf184.
2
SENP2 promotes ESCC proliferation through SETDB1 deSUMOylation and enhanced fatty acid metabolism.SENP2通过SETDB1去SUMO化和增强脂肪酸代谢促进食管鳞癌增殖。
Heliyon. 2024 Jul 2;10(13):e34010. doi: 10.1016/j.heliyon.2024.e34010. eCollection 2024 Jul 15.
3
Inhibition of ABI2 ubiquitination-dependent degradation suppresses TNBC cell growth via down-regulating PI3K/Akt signaling pathway.
抑制ABI2泛素化依赖性降解通过下调PI3K/Akt信号通路抑制三阴性乳腺癌细胞生长。
Cancer Cell Int. 2024 Jun 27;24(1):222. doi: 10.1186/s12935-024-03407-0.
4
Overexpression of Transmembrane Phosphatase with Tensin homology (TPTE) in prostate cancer is clinically significant, suggesting its potential as a valuable biomarker.跨膜磷酸酶与张力蛋白同源物(TPTE)在前列腺癌中的过表达具有临床意义,提示其可能成为有价值的生物标志物。
J Cancer Res Clin Oncol. 2024 Mar 28;150(3):165. doi: 10.1007/s00432-024-05694-6.
5
COSMIC: a curated database of somatic variants and clinical data for cancer.COSMIC:一个针对癌症体细胞变异和临床数据的精选数据库。
Nucleic Acids Res. 2024 Jan 5;52(D1):D1210-D1217. doi: 10.1093/nar/gkad986.
6
Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer.量化癌症患者临床可操作性的扩展领域。
Cancer Discov. 2024 Jan 12;14(1):49-65. doi: 10.1158/2159-8290.CD-23-0467.
7
Targeting Methionine Addiction of Cancer Cells with Methioninase.用甲硫氨酸酶靶向癌细胞的甲硫氨酸成瘾性。
Biochemistry (Mosc). 2023 Jul;88(7):944-952. doi: 10.1134/S0006297923070076.
8
Human genetics seen through an evolutionary lens.从进化视角看人类遗传学。
Cell Genom. 2023 May 10;3(5):100323. doi: 10.1016/j.xgen.2023.100323.
9
Evolutionary constraint and innovation across hundreds of placental mammals.数百种胎盘哺乳动物的进化约束与创新。
Science. 2023 Apr 28;380(6643):eabn3943. doi: 10.1126/science.abn3943.
10
Cancer driver mutations: predictions and reality.癌症驱动突变:预测与现实。
Trends Mol Med. 2023 Jul;29(7):554-566. doi: 10.1016/j.molmed.2023.03.007. Epub 2023 Apr 17.